Showing results (141-150 of 263) with videos related to
Sort By:
Pageof 27
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2018
Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant DiseaseElodie Collinge, Sandrine Loron, Marie-Virginie Larcher, et al.Leukemia Research|October 16, 2015
Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA GroupThomas Smol, Olivier Nibourel, Alice Marceau-Renaut, et al.Blood|January 8, 2005
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 studyVahid Asnafi, Agnes Buzyn, Xavier Thomas, et al.Bone Marrow Transplantation|February 10, 2021
Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemiaCécile Pautas, Emmanuel Raffoux, Juliette Lambert, et al.Blood|July 28, 2005
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotypeNicolas Boissel, Aline Renneville, Valeria Biggio, et al.Mediterranean Journal of Hematology and Infectious Diseases|May 13, 2020
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' StudyMarica Laurino, Sandrine Loron, Marie-Virginie Larcher, et al.Blood|March 18, 2009
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplicationAline Renneville, Nicolas Boissel, Nathalie Gachard, et al.Blood Advances|August 15, 2023
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trialJorge Sierra, Pau Montesinos, Xavier Thomas, et al.Cancer Medicine|February 2, 2022
Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 studyNicolas Boissel, Patrice Chevallier, Vadim Doronin, et al.Genetica|October 23, 2009
The mariner Mos1 transposase produced in tobacco is active in vitroXavier Thomas, Sabah Hedhili, Laurent Beuf, et al.Pageof 27